Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients with Stage I-III Cutaneous Melanoma . J of Skin [Internet]. 2024 Mar. 18 [cited 2025 May 18];8(2):s386. Available from: https://skin.dermsquared.com/skin/article/view/2596